Takeda Pharmaceuticals International GmbH and Sunovion Pharmaceuticals Inc.

Multiple Scientific Posters Supporting the Efficacy, Safety and Tolerability of Once-daily Latuda® (lurasidone) are Presented at the 27th ECNP Congress

Takeda Pharmaceuticals International GmbH ("Takeda") and Sunovion Pharmaceuticals Inc. ("Sunovion") presented new evidence supporting the use of Latuda(R) (lurasidone), an atypical antipsychotic treatment …

OTE0005
21.10.2014 11:48